Events & Presentations
Upcoming Events
ASD Conference 2026
Optimism, Courage, and Pragmatism – Human Pharmacology 2030 Thursday, 24th February 2026 Pre-Meeting Workshop | ...
Innovation for Health 2026
Innovation for Health is the leading conference in the Netherlands, bringing together key stakeholders from across the ...
Open Day at CRS Kiel What Works Tomorrow – Liver Cirrhosis Between Research, Pipeline and Practice
Open Day at CRS Kiel What Works Tomorrow – Liver Cirrhosis Between Research, Pipeline and Practice We are delighted to ...
Networking Evening at CRS Mannheim Cardiometabolic Diseases: The Update
Networking Evening at CRS Mannheim Cardiometabolic Diseases: The Update We are pleased to invite physicians from ...
16th Annual Outsourcing in Clinical Trials Europe 2026
Advance Your Clinical Trials with Insight, Innovation and the Right Partners hVIVO will be attending OCT Europe, with ...
SaxoCell Conference on Cell and Gene Therapy
Explore the Future of Cell and Gene Therapy Development hVIVO will be attending the SaxoCell Conference, a focused ...
11th German Pharm-Tox Summit 2026
The GPTS is organized by the German Society for Experimental and Clinical Pharmacology and Toxicology (DGPT). The ...
World Vaccine Congress Europe
Accelerate Vaccine Development Through Collaboration and Innovation hVIVO will be attending the World Vaccine Congress ...
BIO-Europe 2026
Connect with the Right Partners to Accelerate Biopharma Growth hVIVO will be attending BIO-Europe, the leading ...
Dutch Life Sciences Conference 2026
Connect with Europe’s Leading Life Sciences Ecosystem hVIVO will be attending the Dutch Life Sciences Conference, a key ...
Past Presentations
Capital Markets Day – July 2024
17 July 2024
Capital Markets Day 2024
Sign in to watch below, or download slides.
Past Presentations
Trading Update FY25
HVIVO plc (HVO:AIM) reported an unaudited FY25 trading update highlighting resilient company performance amid a challenging macro backdrop, with revenue of £46.7 million in line with revised guidance and a positive low single-digit adjusted EBITDA margin, outperforming market expectations.
HVIVO PLC - Interim Results
Welcome to the HVO PLC interim results investor presentation.
H1 25 Trading Update
hVIVO's first half 2025 trading update, presented by Yamin Khan
Full Year Results 2024
Financial performance was a record year for hVIVO and also a transformational one for operations.